Manufacturers Life Insurance Company, The Point Biopharma Global Inc. Transaction History

Manufacturers Life Insurance Company, The

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$6.86 - $10.86 $20,806 - $32,938	3,033 Added 9.27%	35,766 $324,000
Q4 2022 Aug 11, 2023	BUY	$5.72 - $9.78 $18,652 - $31,892	3,261 Added 11.06%	32,733 $238,000
Q4 2022 Feb 13, 2023	BUY	$5.72 - $9.78 $18,652 - $31,892	3,261 Added 11.06%	32,733 $238,000
Q3 2022 Aug 11, 2023	SELL	$7.24 - $10.31 $4,901 - $6,979	-677 Reduced 2.25%	29,472 $227,000
Q3 2022 Nov 03, 2022	SELL	$7.24 - $10.31 $4,901 - $6,979	-677 Reduced 2.25%	29,472 $228,000
Q2 2022 Aug 11, 2023	SELL	$5.6 - $9.5 $14,470 - $24,548	-2,584 Reduced 7.89%	30,149 $205,000
Q2 2022 Aug 15, 2022	BUY	$5.6 - $9.5 $168,834 - $286,415	30,149 New	30,149 $205,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.